Gaussian 16, Revision C01, Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Petersson GA, Nakatsuji H, Li X, Caricato M, Marenich AV, Bloino J, Janesko BG, Gomperts R, Mennucci B, Hratchian HP, Ortiz JV, Izmaylov AF, Sonnenberg JL, Williams-Young D, Ding F, Lipparini F, Egidi F, Goings J, Peng B, Petrone A, Henderson T, Ranasinghe D, Zakrzewski VG, Gao J, Rega N, Zheng G, Liang W, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Throssell K, Montgomery JA, Peralta J, Ogliaro JE, Bearpark F, Heyd MJ, Brothers JJ, Kudin EN, Staroverov KN, Keith VN, Kobayashi TA, Normand R, Raghavachari J, Rendell K, Burant AP, Iyengar JC, Tomasi SS, Cossi J, Millam M, Klene JM, Adamo M, Cammi C, Ochterski R, Martin JWRL, Morokuma K, Farkas O
After the addition of 5 L of Annexin V-FITC, the cells were incubated at room temperature for 15 min
First, pills are an ongoing treatment that requires you to remember your dosage on your own
There are currently no randomized, controlled clinical trials examining the effects of BPC-157 in humans
